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Abstract
Background: After being polio free for more than 10 years, an outbreak occurred in China in 2011 in Xinjiang
Uygur Autonomous Region (Xinjiang) following the importation of wild poliovirus (WPV) originating from
neighboring Pakistan.
Methods: To strengthen acute flaccid paralysis (AFP) surveillance in Xinjiang, “zero case daily reporting” and
retrospective searching of AFP cases were initiated after the confirmation of the WPV outbreak. To pinpoint all the polio
cases in time, AFP surveillance system was expanded to include persons of all ages in the entire population in Xinjiang.
Results: Totally, 578 AFP cases were reported in 2011 in Xinjiang, including 21 WPV cases, 23 clinical compatible
polio cases and 534 non-polio AFP cases. Of the 44 polio cases, 27 (61.4%) cases were reported among adults aged
15–53 years. Strengthening AFP surveillance resulted in an increase in the number of non-polio AFP cases in 2011
(148 children < 15 years) compared with 76 cases < 15 years in 2010. The AFP surveillance system in Xinjiang was
sensitive enough to detect polio cases, with the AFP incidence of 3.28/100,000 among children < 15 years of age.
Conclusions: Incorporating adult cases into the AFP surveillance system is of potential value to understand the
overall characteristics of the epidemic and to guide emergency responses, especially in countries facing WPV
outbreak following long-term polio free status. The AFP surveillance system in Xinjiang was satisfactory despite
limitations in biological sample collection.
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Background
Poliomyelitis is a highly infectious disease caused by
poliovirus. One in 200 infections can lead to irreversible
paralysis. There is no cure for poliomyelitis, it can only
be prevented through immunization of polio vaccine
which is given multiple times and almost always protects
a child for life. Poliomyelitis is one of the limited num-
bers of diseases that can be eradicated, as it only affects
humans, an effective vaccine is available, and, moreover,
immunity is lifelong. In 1988, the World Health Assembly
resolved to eradicate poliomyelitis by 2000 [1,2]. Subse-
quently, the Global Polio Eradication Initiative reduced
wild poliovirus (WPV) cases from an estimated 350,000 in
1988 to 650 reported cases in 2011, and indigenous trans-
mission of type 2 WPV had been interrupted globally
since 1999 [3].
Poliomyelitis had been historically endemic and wide-
spread in China and stopping WPV transmission had been
pursued through a combination of routine immunization
and supplementary immunization activities (SIAs) based
on high quality surveillance. Eventually, the last case
of poliomyelitis due to transmission of indigenous WPV
occurred in China in September 1994, and the Western
Pacific Region has been certified as polio free since 2000
* Correspondence: yangwz@chinacdc.cn; llsdjn@163.com
1Chinese Center for Disease Control and Prevention, 27 Nanwei Rd, Xicheng
District, Beijing 100050, PR China
Full list of author information is available at the end of the article
© 2014 Wen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Wen et al. BMC Infectious Diseases 2014, 14:113
http://www.biomedcentral.com/1471-2334/14/113
[4,5]. However, given the risk of WPV importation from
areas where indigenous WPV transmission has never been
interrupted, it is important to guarantee high quality sur-
veillance, as many previously polio free countries have
been affected by WPV importation [5-8].
WPV surveillance is conducted through reporting and
laboratory testing of fecal specimens for all cases of
acute flaccid paralysis (AFP) among children <15 years
of age. An AFP case is defined as a child < 15 years of
age showing acute or sudden onset of flaccid paralysis in
one or more limbs, or other suspected poliomyelitis in a
person of any age [9]. Two key performance indicators
are monitored for AFP surveillance: 1) AFP surveillance
system should be sensitive enough to detect at least 1
case of non-polio AFP per 100,000 children <15 years of
age; 2) ≥ 80% of AFP cases have adequate collection of
two fecal specimens within 14 days of the onset of par-
alysis (≥ 24 hours apart) [10]. A WPV case was defined
as an AFP case for whom a stool specimen tested posi-
tive for WPV by virology, while a clinical compatible
polio case was defined as an AFP case for whom stool
specimens were missing or tested negative for WPV, but
was determined to be polio-compatible by the provincial
Polio Expert Committee of China after the standard 60-
day follow-up examination. WPV importation has been
a continuous threat to China which had experienced
WPV importation historically [11-13], as it shares bor-
ders with 2 of the remaining 3 countries that had never
interrupted WPV transmission as of 2012. On August
25, 2011, an outbreak following importation of WPV
originated from neighboring Pakistan was confirmed in
Xinjiang Uygur Autonomous Region (Xinjiang), China,
after being polio free for more than 10 years. To detect
potential polio cases, AFP surveillance was intensified in
Xinjiang after the confirmation of the WPV outbreak. In
this report, we describe the performance of intensified
AFP surveillance compared with previous surveillance
methods, as well as the epidemiological characteristics
of AFP cases in Xinjiang.
Methods
Organization of AFP surveillance in China
In 1991, an active system of AFP surveillance with a tar-
get population <15 years of age was initially established,
limited to representative regions of China located in dif-
ferent parts of the country. In 1993, the surveillance was
extended to the national level and was conducted by the
Chinese Center for Disease Control and Prevention (China
CDC) under the leadership of the Ministry of Health.
Every case of AFP <15 years of age or clinical diag-
nosed polio cases at any age are reported to the county
CDC through telephone or written report card by hospital
physicians. After receiving case reports, the staffs of the
county CDC conduct an epidemiological investigation and
collect two stool specimens from each case for viro-
logical investigation within 14 days since the onset of
paralysis. Stool specimens are placed in refrigerated
containers and subsequently forwarded to the provincial
polio laboratory where viral isolation is performed on
L20B and RD cell cultures, and viral isolates are iden-
tified by micro-neutralization assays. Poliovirus isolates
are forwarded to the National Polio Laboratory where
intratypic differentiation is performed by polymerase
chain reaction–restriction fragment–length polymorph-
ism (PCR) and by enzyme-linked immunosorbent assay
(ELISA). All tests are processed according to the standard
guidelines recommended by World Health Organization
(WHO). The National Polio Laboratory is part of the
WHO Global Polio Laboratory Network and is fully
accredited by the WHO as a regional reference polio
laboratory.
Comprehensive hospitals at the county-level and above,
the neurology specialized hospital, children’s hospital, in-
fectious disease hospital, and the comprehensive hospital
of Traditional Chinese Medicine are included as active
surveillance hospitals, in which active searching of AFP
cases are conducted to detect under-reported cases every
10 days by the county CDC.
Intensifying active surveillance of AFP cases in Xinjiang
On August 28, 2011, immediately after confirmation of the
WPV outbreak, “zero case daily reporting” (daily reporting
even if no AFP cases have been found) was initiated in hos-
pitals at the township level and above targeting AFP cases
of all age groups in southern Xinjiang (where WPV trans-
mission was limited, including Hotan, Kashgar, Bayingolin,
Kezilesukeer and Akesu) and Urumqi (the capital city
in Xinjiang), and in hospitals at the county-level and
above targeting AFP cases <15 years in other prefec-
tures (Table 1) as suspected polio cases (determined by
clinicians without laboratory testing results) were also
identified among adults. In keeping with definitions
used in previous polio outbreaks, age ≥ 15 years was
used to define adults [14-16].
Retrospective searching of AFP cases in Xinjiang
Retrospective searches of AFP cases were launched on
August 28, 2011 in Xinjiang, aiming to detect under-
reported AFP cases who sought health care from January
1, 2010 to August 28, 2011. In every selected hospital,
both outpatient and inpatient records were checked in
the pediatric department, neurology department, in-
ternal medicine department and the infectious disease
department. Retrospective searches were conducted in
hospitals at the township-level and above for southern
Xinjiang and Urumqi, and in hospitals at the county-
level and above in the remaining prefectures in Xinjiang.
Case definitions for different areas are shown in Table 1.
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Ethical consideration
Based on WHO guidelines of AFP surveillance for the
objective of poliomyelitis eradication, AFP surveillance is
routinely conducted by the China CDC and the target
population was expanded to improve the ability of AFP
surveillance to detect potential polio cases in Xinjiang.
The study was approved by the Chinese Center for Dis-
ease Control and Prevention institutional review board.
Statistical analysis
Statistical tests were performed using SAS 9.1 software
(SAS Institute Inc, Cary, NC, USA). Comparisons between
groups were conducted using chi-square and Fisher’s exact
tests for categorical variables. A p-value of <0.05 was con-
sidered statistically significant for all analyses.
Results
AFP surveillance in Xinjiang
Totally, 578 AFP cases were reported in 2011 in Xinjiang,
including 21 WPV cases, 23 clinical compatible polio
cases and 534 non-polio AFP cases (Table 2). Of the 578
AFP cases, 28 were < 1 year of age, 80 between 1 and 4
years, 57 between 5 and 14 years, 224 between 15 and
39 years, and 189 were ≥ 40 years of age. Of the 534
non-polio AFP cases, 145 (27.2%) were diagnosed as
Guillain Barré syndrome and 111 (20.8%) with hypokal-
emic periodic paralysis.
Active surveillance and retrospective searches imple-
mented after confirmation of the WPV outbreak, re-
sulted in an increase in the number of non-polio AFP
cases in 2011 (148 children < 15 years in 2011 compared
Table 1 The definition of AFP case for zero case daily reporting and retrospective searching
AFP surveillance Areas Hospitals AFP case definition
Zero case daily reporting Southern Xinjiang and Urumqi Hospitals at township
level and above
AFP cases at any age
Other prefectures Hospitals at county
level and above
AFP case <15 years or suspected polio cases at any age
Retrospective searching Southern Xinjiang and Urumqi Hospitals at township
level and above
AFP case <15 years old, suspected polio case at any age in 2010;
AFP case at any age, paralyzed from January 1 to August 28, 2011
Other prefectures Hospitals at county
level and above
AFP case <15 years old, or suspected polio case at any age,
paralyzed from January 1, 2010 to August 28, 2011
Note: AFP acute flaccid paralysis.
Table 2 OPV immunization history of AFP cases by classification of AFP cases and age in 2011 in Xinjiang
Classification of AFP cases Age (years) No. 0 dose 1-2 doses ≥ 3 doses Unknown
N (%) N (%) N (%) N (%)
WPV cases < 1 6 3 (50.0) 1 (16.7) 2 (33.3) 0 (0)
1-4 4 0 (0) 1 (25.0) 3 (75.0) 0 (0)
5-14 0 0 (0) 0 (0) 0 (0) 0 (0)
15-39 10 2 (20.0) 1 (10.0) 0 (0) 7 (70.0)
≥ 40 1 0 (0) 0 (0) 0 (0) 1 (100.0)
Total 21 5 (23.8) 3 (14.3) 5 (23.8) 8 (38.1)
Clinical compatible polio cases < 1 3 2 (66.7) 0 (0) 1 (33.3) 0 (0)
1-4 3 0 (0) 1 (33.3) 2 (66.7) 0 (0)
5-14 1 0 (0) 0 (0) 0 (0) 1 (100.0)
15-39 14 1 (7.1) 1 (7.1) 1 (7.1) 11 (78.6)
≥ 40 2 0 (0) 0 (0) 0 (0) 2 (100.0)
Total 23 3 (13.0) 2 (8.7) 4 (17.4) 14 (60.9)
Non-polio AFP cases < 1 19 2 (10.5) 7 (36.8) 8 (42.1) 2 (10.5)
1-4 73 0 (0) 1 (1.4) 63 (86.3) 9 (12.3)
5-14 56 1 (1.8) 1 (1.8) 38 (67.9) 16 (28.6)
15-39 200 7 (3.5) 23 (11.5) 8 (4.0) 161 (81.0)
≥ 40 186 16 (8.6) 2 (1.1) 1 (0.5) 167 (89.8)
Total 534 26 (4.9) 34 (6.4) 118 (22.1) 356 (66.7)
Note: OPV oral attenuated poliovirus vaccine, AFP acute flaccid paralysis, WPV wild poliovirus.
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with 76 cases <15 years in 2010) (Figure 1). Of the 148
non-polio AFP cases <15 years reported in 2011, 114
(77.0%) cases had adequate fecal specimens, 18 (12.2%)
cases had inadequate specimens, and 16 (10.8%) cases
did not provide fecal specimens; while in 2010, 63
(82.9%) cases had adequate fecal specimens and 12
(17.1%) cases had inadequate specimens.
Of the 386 non-polio AFP cases ≥ 15 years reported in
2011, 98 (25.4%) cases had adequate fecal specimens, 51
(13.2%) cases had inadequate specimens and 237 (61.4%)
cases did not provide fecal specimens (Figure 2). Spe-
cimens were not collected among almost all AFP cases
≥ 15 years before the confirmation of WPV outbreak.
However, of the 158 non-polio AFP cases who were
paralyzed after the confirmation of the WPV outbreak,
94 (59.5%) cases had adequate fecal specimens, 36 (22.8%)
cases had inadequate specimens, and 28 (17.7%) cases did
not provide fecal specimens.
WPV and clinical compatible polio cases
WPV and clinical compatible polio cases were limited to
four southern prefectures (Figure 3): Hotan (13 WPV
cases and 19 clinical compatible polio cases), Kashgar
(6 WPV cases and 3 clinical compatible polio cases),
Bayingolin (1 WPV case), and Akesu (1 WPV case and
1 clinical compatible polio case). The first WPV case
was paralyzed on July 3, while the last WPV case was
paralyzed on October 9. The first clinical compatible
polio case was paralyzed on July 5, while the last clin-
ical compatible case was paralyzed on October 4. The
first adult WPV case was paralyzed on July 22, and the
first adult clinical compatible polio case was paralyzed
on July 5. Six clinical compatible polio cases were para-
lyzed after the confirmation of the WPV outbreak, in
which 2 cases were younger than 15 years of age.
Based on the population in the four southern prefec-
tures, WPV and clinical compatible polio cases incidence
were 0.22/100,000 and 0.24/100,000, respectively, both
with highest incidence among children <1 year (3.46/
100,000 and 1.15/100,000, respectively), followed by chil-
dren aged 1–4 years (both 0.64/100,000). No WPV cases
were reported among children aged 5–14 years, and only
1 clinical compatible polio case was reported. More than
half (27/44 (61.4%)) of polio cases were reported among
adults aged 15–53 years. The WPV incidence among
males (0.29/100,000) was higher than among females
(0.15/100,000), as was the incidence of clinical compat-
ible polio cases among males (0.41/100,000) compared
with females (0.06/100,000).
Oral attenuated poliovirus vaccine (OPV) immunization
history of AFP cases
Of the 578 AFP cases reported in 2011, only 127 (22.0%)
cases received ≥ 3 doses OPV, and 378 (65.4%) cases did
not have detailed OPV immunization histories, of which
349 (92.3%) were adults cases. Totally, 70.9% (117/165)
of cases among children received ≥ 3 doses OPV and
4.9% (8/165) did not receive any OPV doses. Among
AFP cases < 1 year of age, 3 (50.0%) WPV cases, 2
(66.7%) clinical compatible polio cases and 2 (10.5%)
non-polio AFP cases did not receive any OPV doses.
Among the 200 AFP cases with known immunization
histories, there were significantly more non-polio AFP
cases that received ≥ 3 doses OPV than polio cases (in-
cluding WPV cases and clinical compatible polio cases:
66.3% (118/178) and 40.9% (9/22), respectively; P = 0.02).
Performance of AFP surveillance system in Xinjiang
The reported non-polio AFP incidence in Xinjiang was >1
per 100,000 children <15 years of age during 2006–2010,
Figure 1 Weekly distribution of AFP cases < 15 years by classification and sample collection in 2010 and 2011 in Xinjiang.
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but the collection rates of adequate stool specimens
were lower than 80% in 2008 and 2009. After the com-
prehensive strengthening of the AFP surveillance sys-
tem, the reported incidence of AFP (3.28/100,000)
among children <15 years of age in Xinjiang in 2011,
was nearly twice more than that in 2010 (1.63/
100,000). Most importantly, there were also increases
for system sensitivity in southern Xinjiang: Hotan
0.82/100,000 vs. 3.40/100,000, Kashgar 1.86/100,000
vs. 4.34/100,000, Akesu 1.20/100,000 vs. 2.76/100,000,
and Bayinguole 1.25/100,000 vs. 4.48/100,000. In 2011, the
reported incidences of AFP were higher than 2/100,000
(target required by WHO for polio epidemic countries)
among children < 15 years of age in all but Yili
Prefecture.
However, in 2011, some timely indicators of AFP sur-
veillance system at the provincial and prefectural levels
did not meet the target required by the Ministry of
Health and WHO. The proportion of AFP cases with 2
adequate stool specimens collected within 14 days of
paralysis onset did not meet the target of ≥ 80% in
Xinjiang (77.0%), Hotan (52.9%) and Kashgar (76.7%).
Figure 2 Weekly distribution of AFP cases ≥ 15 years by classification and sample collection in 2011 in Xinjiang.
Figure 3 Distribution of laboratory confirmed WPV cases and clinical compatible. Polio Cases in Xinjiang in 2011.
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Discussion
This report documents the performance of an intensified
AFP surveillance system in Xinjiang following WPV im-
portation from neighboring Pakistan. Totally, 578 AFP
cases were reported in 2011 in Xinjiang, including 21
WPV cases and 23 clinical compatible polio cases. Based
on active surveillance and high quality retrospective
searches, the number of non-polio AFP cases reported
in Xinjiang in 2011 was nearly twice more than that in
2010. This was a limited transmission of WPV in Xinjiang,
as WPV cases and clinical compatible polio cases were
confined to four southern prefectures: Hotan, Kashgar,
Bayingolin, and Akesu. Children less than 5 years of age
were most likely exposed and vulnerable to the virus, how-
ever, adults who accounted for more than 50% of polio
cases may be an important source of infection for chil-
dren. For timely detection of adult polio cases, adults with
AFP were also incorporated into the AFP surveillance sys-
tem in Xinjiang.
The primary objective of AFP surveillance is to detect,
investigate, report and promptly implement an emer-
gency response. Detecting and investigating all cases
of non-polio AFP in the children <15 years of age are
among the most important criteria for polio free certifi-
cation. In recent years, the reported incidence of non-
polio AFP cases was efficient and even exceeded the
WHO-established minimum target of 1 non-polio AFP
case per 100,000 children. However, the number of non-
polio AFP cases in Xinjiang doubled after active AFP
surveillance was strengthened following WPV import-
ation in 2011 compared with 2010. Therefore, although
routine AFP surveillance in polio free countries usually
meets the WHO-established requirement, in order to ob-
tain prompt reports of AFP cases after WPV is imported
and results in onward transmission, intensified active AFP
surveillance and retrospective searches should be con-
ducted. Another important criterion of AFP surveillance is
adequate collection of two stool specimens within 14 days
of paralysis onset. The indicator in 2011 did not meet the
target of ≥ 80% in Xinjiang (77.0%), Hotan (52.9%) and
Kashgar (76.7%). Moreover, 6 clinical compatible polio
cases were reported after active AFP surveillance was
strengthened following WPV importation, in which there
were 2 cases <15 years of age. These cases were classified
as compatible because of inadequate stool collection,
therefore, the potential factors contributing to inadequate
stool collection should be identified and addressed so that
AFP surveillance system can be improved by minimizing
the time between paralysis onset, case notification, investi-
gation and sample collection. In order to achieve the opti-
mal standards recommended by WHO, both in case
reporting and in the collection of stool specimens, greater
attention and involvement of clinicians and other health
workers is needed [17].
Adults aged 15–39 years accounted for more than 50%
of polio cases, although with relatively low incidence.
Any country with no recent WPV transmission may face
similar outbreaks characterized by a large proportion of
cases in older age groups. [7,16,18-21] It was found that
antibody seroprevalence decreased with increasing age
[22], and seroprotection rates and GMTs were low in
both adolescents and adults [23]. In order to detect all
the polio cases in time and interrupt the potential trans-
mission of WPV, adult AFP cases were also incorporated
into AFP surveillance system in Xinjiang after the con-
firmation of the WPV outbreak. As far as we know, this
was the first time that adult AFP cases were monitored
with the same WHO requirement as child AFP cases.
This was found to be a useful way to understand the
overall epidemic and to discover the index case. After
index polio cases were detected, a series of epidemio-
logical investigations and emergency response activities
were implemented to prevent WPV transmission, such
as serological surveys, poliovirus surveillance for close
contacts of AFP cases and healthy children, environmen-
tal surveillance, cleaning and disinfection of toilets used
by polio cases, and SIAs [24]. In addition to polio cases,
WPV was also isolated from healthy children, close con-
tacts of AFP cases, and environmental samples collected
in Kashgar and Hotan prefectures. WPV strains were
isolated in Beijing among 3 healthy students from Hotan
prefecture [24]. Based on the findings from this 2011
AFP surveillance in Xinjiang, the target population for
SIAs was expanded to <40 years in southern Xinjiang.
Five rounds of SIAs were conducted in Xinjiang from
August 2011 to April 2012, with a total of 43.7 million
doses of OPV administered, which led to the quick
restriction of WPV transmission [24]. The incidence of
polio cases was higher among males than females (WPV
incidence: 0.29/100,000 vs. 0.15/100,000; incidence of
clinical compatible polio cases: 0.41/100,000 vs. 0.06/
100,000). It has been observed that clinical manifesta-
tions of poliovirus are more common among males than
females [25], even though males and females share simi-
lar vaccination coverage. There are two possible assump-
tions as to why males had higher polio incidence than
females: among Uygur minorities, males may have more
opportunities to participate in public activities, which
puts them at higher risk of infection and women in the
young adult age groups may have additionally benefitted
from exposure to excreted OPV while caring for the
young [26].
It was not surprising that more non-polio AFP cases
received ≥ 3 doses OPV than polio cases. OPV induced
immunity had been well proven, OPV has been the main
tool in the WHO polio eradication program and many
countries have achieved polio eradication by OPV
immunization. In 2011, only 70.9% (117/165) children
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AFP cases received ≥ 3 doses OPV, and 4.9% (8/165) did
not receive any OPV doses in Xinjiang. The reported
number of OPV doses of non-polio AFP cases can be
used as a proxy measure of OPV coverage [27]. A sero-
logical study was conducted to estimate poliovirus anti-
body seroprevalence in 2010, immediately prior to the
2011 WPV importation into Xinjiang [22]. Almost all
(95.8%) children <15 years of age in Xinjiang were sero-
positive to type 1 poliovirus, which is comparative to
the estimation of OPV coverage by AFP surveillance
system that 4.9% of non-polio AFP cases <15 years of
age were not immunized in 2011. The low rate of full
OPV immunization (≥3 doses) among child AFP cases
which suggests a gap in immunization status or the pres-
ence of parts of population not immunized, together with
immigrants and emigrants from and to Pakistan, may lead
to another WPV outbreak in Xinjiang.
Conclusions
Incorporating adult AFP cases into AFP surveillance
system is of potential value to understand the overall
characteristics of the epidemic and to guide emergency
response, especially in countries facing WPV outbreak
following long-term polio free status. Case reporting by
AFP surveillance and subsequent laboratory diagnosis
were essential to evaluate the interruption of WPV
circulation. The AFP surveillance system in Xinjiang
was satisfactory despite limitations in biological sample
collection. In order to achieve the optimal standards
recommended by WHO, both in case reporting and in
the collection of stool specimens, greater attention and
involvement of clinicians and other health workers is
needed.
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